Skip to main content

OPINION article

Front. Pharmacol.
Sec. Drugs Outcomes Research and Policies
Volume 15 - 2024 | doi: 10.3389/fphar.2024.1429435

Challenges for esketamine nasal spray in China: Use and management

Provisionally accepted
  • 1 The Affiliated Mental Health Center, Jiangnan University, Wuxi, Liaoning Province, China
  • 2 Northern Jiangsu People's Hospital, Yangzhou University, Yangzhou, Jiangsu Province, China

The final, formatted version of the article will be published soon.

    Keywords: Challenges, Esketamine nasal spray, China, use, Management

    Received: 08 May 2024; Accepted: 23 Sep 2024.

    Copyright: © 2024 Wu, Gu, Qiu, Jin and Zhou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Zhenhe Zhou, The Affiliated Mental Health Center, Jiangnan University, Wuxi, 214151, Liaoning Province, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.